Figure 4.

Ad5-ASFV elicited antibody responses. Following priming and boosting, recombinant pp62 antigen was used to track IgG responses by ELISA using sera from blood collected: (A) 1-week post-priming; (B) 3 weeks post-priming; or (C) 1 week after the second boost. Mean responses for the treatment groups are denoted by bars and statistically significant differences between the groups are denoted by asterisks, *p = 0.002, **p = 0.005, ***p < 0.0001, any groups not denoted with an asterisk were not statistically significant.